Auddia Inc. (AUUD) · Oct 22, 2026 · Material agreement
Additional bridge funding — Original bridge-note caps total $1.40M; amended amount not disclosed
Auddia’s bridge-funding amendment supports its proposed AI holding-company merger, but the filing leaves the added funding amount and terms unclear.
Auddia is trying to transform from an audio-technology company into the public parent of three early-stage AI businesses—LT350, Influence Healthcare, and Voyex—through its proposed McCarthy Finney merger. This filing keeps that transition funded, not completed. The company says the bridge notes provide interim funding and working capital while the merger remains pending. 〔0〕
| Bridge-note recipient | Original maximum funding |
|---|---|
| Thramann Holdings | $360,000 |
| LT350 | $400,000 |
| Influence Healthcare | $590,000 |
| Voyex | $50,000 |
| Total | $1.40 million |
The signal is operationally useful but financially opaque. Auddia is seeking additional interim funding for the merger targets, yet the provided filing content does not state the amended caps, the amount already drawn, the interest terms, or whether any new security or conversion feature was added. That prevents a clean assessment of how much more cash runway this creates or how much additional exposure Auddia is taking on. The original notes were expressly limited to the pending merger and stop further funding if that deal terminates. 〔1〕
Relative to the standing story, this is partly new rather than a new strategic direction. The merger and the bridge-financing mechanism were already disclosed; the incremental information is that the target companies still need more interim support while the transaction remains unresolved. That modestly advances the AI-platform plan, but it also reinforces that the businesses are early-stage and not yet self-funding. The filing does not itself provide evidence that the merger has closed or that the underlying companies have reached commercial scale.
Bottom line: This is a support measure for a still-pending merger, not a business milestone. It helps keep the proposed AI platform moving, but the missing amendment economics leave the funding burden—and therefore the net impact—unclear.
Merger closing and stockholder approval
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!